Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

NCT00791557 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Pyoderma Gangrenosum
Crohn's Disease
Ulcerative Colitis
Inflammatory Bowel Disease

Interventions

DRUG: Infliximab

Sponsor

University Hospitals Cleveland Medical Center

Collaborators

[object Object]